Clinical Evaluation of Ultrasonic Hydration Monitor for Infants

Artann Laboratories42 enrolled

Overview

Study will verify ability of infant Hydration Monitor (IHM) to assess changes of hydration status in newborns and infants by means of ultrasound velocity measurements through muscle tissues. Changes of tissue hydration will be followed during first days of life in newborns and in acute diarrhea in small children during re-hydration therapy. Weighting and clinical dehydration symptoms will be used as controls.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diarrhea Dehydration

Eligibility

Sex: ALLMin age: 1 DayMax age: 3 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Newborns from 1 to 7 days old, * Health infants from 1 month to 3 years old, * Any ethnicity, * Male or female, * Infants with diarrhea, * Acute gastroenteritis, * Diarrhea and/or vomiting, * Suspected dehydration Exclusion Criteria: * Congenital heart disease, * Renal failure, * Chronic liver disease, * Chronic lung disease, * Inflammatory bowel disease, * Immune deficiency, * Severe malnutrition, * Any external damage to skin of leg, * Infants and Children whose parents refuse permission to be included

Locations (1)

Children Clinical University Hospital (CCUH) of the Riga Stradinsh University (RSU)

Riga, Latvia

Outcomes

Primary Outcomes

Assess the ability of IHM to measure changes of hydration status ni newborn and infants

Infants and small children diagnosed with diarrhea or presenting to the hopsital with diseases known to cause dehydration are eligible

Time frame: 1 week to several months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.